Bausch + Lomb announced the U.S. launch of Arise, a cloud-based intelligent lens-fitting system designed to streamline the orthokeratology lens design process. Arise is U.S. Food and Drug Administration–approved and is the first fitting system to feature toric peripheral curves, which optimize myopia correction for overnight wear without traditional fitting sets.
The Arise system integrates advanced artificial intelligence algorithms to interpret corneal topography images and generate precise lens designs within seconds. According to a press release from Bausch + Lomb, the system is designed for eye care professionals of all experience levels and offers automated lens recommendations, overnight outcome maps to evaluate centration and patient progress, cloud-based access to secure patient data, and direct support from Bausch + Lomb’s consultation team. It also offers increased efficiency with reduced chair time and improved patient outcomes, Yang Yang, President of Global Vision Care at Bausch + Lomb, said in the press release.
Myopia prevalence is projected to increase to 50% of the global population by 2050, and orthokeratology is gaining attention as a nonsurgical management option.
Arise supports the Boston Orthokeratology (oprifocon A) shaping lenses, which are indicated for:
- Temporary reduction of myopia up to –5.00D
- Astigmatism correction up to 1.50D
- Overnight wear under the Vision Shaping Treatment process.
The shaping lenses are not recommended for patients with ocular infections or inflammation, severe dry eye, corneal abnormalities, or systemic diseases affecting the eyes. Risk of ulcerative keratitis increases with extended wear, and smoking further elevates this risk. For more information on contraindications, safety, and clinical trial data, refer to the press release.
Arise is now available in the United States, United Kingdom, and Europe.